Group 1 - eHealth, Inc. (NASDAQ: EHTH) was recommended for purchase at $6.78 based on favorable enrollment numbers and stock momentum [1] - The company is focused on providing investment strategies that aim to enhance savings and retirement timelines through a blended trading and income approach [1] Group 2 - The company is currently offering a promotional discount of 20% on its services through the EHTH article [1] - There is a light version of the company's service available for 55 cents a day, which includes various benefits [2]

Q4 & FY 2024 Financial Results ©2025 eHealthInsurance Services, Inc. 1 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the federal securities laws. Forward-looking statements generally relate to future events or our future financial or operating performance. Forward-looking statements in this presentation include, but are not limited to, the following: our estimates regarding Medicare enrollment growth; our estimates regarding comm ...

Revenue Growth - Q4 2024 total revenue reached $315.2 million, a 27% increase from $247.7 million in Q4 2023, primarily driven by Medicare segment growth[5] - FY 2024 total revenue was $532.4 million, an 18% increase from $452.9 million in FY 2023[5] - Total revenue for the three months ended December 31, 2024, was $315,181,000, representing a 27% increase compared to $247,662,000 in the same period of 2023[20] - The consolidated total revenue rose by 27% to $315,181,000 for the three months ended December 31, 2024, from $247,662,000 in the prior year[30] - Non-GAAP total revenue excluding net adjustment revenue for 2024 was $509,675,000, a 26% increase from $404,796,000 in 2023[47] Profitability - Q4 2024 GAAP net income was $97.5 million, an 87% increase compared to $52.2 million in Q4 2023[5] - FY 2024 net income was $10.1 million, a significant turnaround from a net loss of $28.2 million in FY 2023[5] - The company reported a significant increase in net income attributable to common stockholders, reaching $85,687,000 for the three months ended December 31, 2024, compared to $41,691,000 in the same period of 2023[20] - Non-GAAP net income for Q4 2024 was $91,797,000, up from $40,379,000 in Q4 2023[46] - The income before income taxes surged by 89% to $110,473,000 for the three months ended December 31, 2024, compared to $58,469,000 in the same period of 2023[30] Medicare Segment Performance - Total Medicare submissions grew 38% year-over-year in Q4 2024, with Medicare Advantage submissions increasing by 42%[5] - The Medicare segment primarily consists of commissions from Medicare-related health insurance plans, contributing significantly to revenue growth[25] - Total revenue for the Medicare segment increased by 31% to $305,781,000 for the three months ended December 31, 2024, compared to $233,680,000 in the same period of 2023[28] - The gross profit for the Medicare segment increased by 56% to $159,880,000 for the three months ended December 31, 2024, compared to $102,357,000 in 2023[28] - Medicare Advantage approved members increased to 366,160 in 2024 from 290,712 in 2023, a growth of 26%[38] Future Projections - The company expects 2025 total revenue to be in the range of $510.0 million to $550.0 million[12] - 2025 adjusted EBITDA is projected to be between $35.0 million and $60.0 million[12] - The company anticipates an 8% CAGR for revenue from 2023 to 2025, with an implied adjusted EBITDA margin of 9% for 2025[7] - The company expects a GAAP net loss attributable to common stockholders in 2025 to range from $(60.0) million to $(35.0) million[50] Operating Costs and Expenses - Total operating costs and expenses for the three months ended December 31, 2024, were $202,541,000, an 8% increase from $188,294,000 in the same period of 2023[20] - Marketing and advertising expenses for the three months ended December 31, 2024, were $96,197,000, a 9% increase from $87,959,000 in the same period of 2023[20] - Variable marketing and advertising costs for the consolidated segment increased by 11% to $88,002,000 for the three months ended December 31, 2024[30] Membership and Acquisition Metrics - The number of approved Medicare members increased by 33% to 248,440 for the three months ended December 31, 2024, compared to 186,567 in 2023[36] - Total approved members rose to 485,456 in 2024, up 13% from 429,196 in 2023[38] - Estimated Medicare Advantage membership reached 690,874 in 2024, an 11% increase from 622,896 in 2023[39] - The total acquisition cost per Medicare Advantage-equivalent approved member decreased by 23% to $591 for the three months ended December 31, 2024[36] Financial Reporting and Measures - eHealth reported non-GAAP total revenue excluding net adjustment revenue, which provides a clearer view of the company's financial performance[55] - Non-GAAP operating costs and expenses were calculated by excluding stock-based compensation and other charges, reflecting a more accurate operational cost structure[56] - Adjusted EBITDA margin was derived from adjusted EBITDA divided by revenue, offering insights into profitability trends[56] - eHealth continues to emphasize the importance of non-GAAP financial measures to provide investors with a comprehensive view of its operating performance[54]

Financial Results - eHealth, Inc. announced its financial results for the fourth quarter and fiscal year ended December 31, 2024 [1] - The company reported significant growth in its online health insurance marketplace, highlighting its role as a leading independent licensed insurance agency [4] Conference Call Information - A webcast and conference call regarding the financial results will be held on February 26, 2025, at 8:30 a.m. Eastern Time [3] - Interested participants can join the call by dialing (800) 549-8228 with the participant passcode 72156 [3] Company Overview - eHealth has been operational for over 25 years, assisting millions of Americans in finding suitable healthcare coverage [4] - The company provides access to over 180 health insurers, including both national and regional companies [4]

Core Viewpoint - Fortrea has appointed Erin L. Russell as a new independent member of its Board of Directors, following a cooperation agreement with Starboard Value LP, which owns approximately 5.4% of Fortrea's outstanding common stock [1][2]. Company Summary - Fortrea is a leading global contract research organization (CRO) that provides clinical development solutions to the life sciences industry, partnering with biopharmaceutical, biotechnology, medical device, and diagnostic companies [5]. - The company offers phase I-IV clinical trial management, clinical pharmacology, and consulting services, leveraging over 30 years of experience across more than 20 therapeutic areas [5]. Board Appointment - Erin L. Russell brings extensive experience in finance and healthcare, having held executive and board roles in various companies, including Modivcare, eHealth, and Kadant [2]. - Russell's previous board experience includes Tivity Health, DeVilbiss Healthcare, DynaVox, and 21st Century Oncology [2]. - She has a background in private equity, having spent 16 years as a principal at Vestar Capital Partners [2]. Cooperation Agreement - The cooperation agreement with Starboard includes a customary standstill and voting agreement, with Starboard having the right to appoint a representative to the Board under certain conditions starting in August 2025 [3]. - Both Fortrea and Starboard expressed positive sentiments regarding their collaboration, emphasizing the goal of driving financial improvements and maximizing shareholder value [2][3]. Advisory and Legal Counsel - Barclays is serving as the financial advisor to Fortrea, while White & Case LLP and Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan, LLP are providing legal counsel to Fortrea [4]. - Starboard is represented by Olshan Frome Wolosky LLP as its legal counsel [4].

Company Overview - eHealth (EHTH) shares increased by 6.4% to close at $10.45, with notable trading volume compared to typical sessions, while the stock gained 0.8% over the past four weeks [1] - The company is expected to benefit from strong Medicare Advantage enrollment growth and has made significant progress in enhancing its tele sales organization [2] Revenue and Earnings Expectations - eHealth is projected to report quarterly earnings of $1.91 per share, reflecting an 18.6% year-over-year increase, with revenues expected to reach $270.08 million, a 9.1% increase from the previous year [4] - The consensus EPS estimate for eHealth has remained unchanged over the last 30 days, indicating that stock price movements may not continue without trends in earnings estimate revisions [6] Strategic Focus - The company is focused on developing a local market-oriented, omni-channel enrollment engine to improve conversion rates and margins, while expanding its product portfolio beyond Medicare Advantage [3] - This strategic focus is anticipated to drive revenue growth and generate positive adjusted EBITDA [3]

Group 1 - eHealth, Inc. plans to release its fourth quarter and fiscal year 2024 financial results on February 26, 2025 [1] - An earnings conference call will be held on the same day at 8:30 a.m. Eastern Time, hosted by CEO Fran Soistman and CFO John Dolan [2] - A live webcast of the earnings call will be available on the Investor Relations page of the company's website, with a replay accessible for one year [3] Group 2 - eHealth has been operating for over 25 years, assisting millions of Americans in finding affordable healthcare coverage [4] - The company is an independent licensed insurance agency, providing access to over 180 health insurers, including both national and regional companies [4] - For further information, eHealth encourages visits to their website and social media platforms [4]

Core Insights - eHealth, Inc. has launched Iris by eHealth, an Individual Coverage Health Reimbursement Account (ICHRA) solution aimed at helping employers manage healthcare costs while providing employees with personalized health plan options [1][2] Group 1: Cost Savings and Flexibility - Employers can potentially save an average of 17% on healthcare costs by utilizing ICHRA, allowing employees to select health plans that meet their unique needs [2][4] - The ICHRA model addresses the healthcare needs of diverse workforces, including geographically dispersed, seasonal, and mixed part-time and full-time employees [2] Group 2: User Experience and Support - Employers have reported satisfaction with the cost savings and the increased plan options available to employees through the individual market [3] - eHealth provides comprehensive support, including no plan markups or hidden fees, and offers a free annual review of plan options [3][7] Group 3: Functionality of Iris Platform - The Iris platform allows employers to set a flat monthly contribution towards each employee's health coverage, while employees can choose plans from various top insurance companies [7] - Employees can customize their plan selections by adding preferred doctors and prescriptions, ensuring their choices align with personal healthcare needs [7]

Group 1 - eHealth, Inc. (NASDAQ: EHTH) stock is experiencing significant gains, indicating potential for further upside in the small-cap sector [1] - The company operates as an online private health insurance marketplace, which has faced challenges in the current market environment [1]

Core Insights - eHealth, Inc. reported strong performance during the Annual Enrollment Period (AEP), driven by significant changes in Medicare Advantage and Part D plan offerings, leading to increased demand for its services [2][3] - The company has revised its fiscal year 2024 guidance, indicating improved revenue and adjusted EBITDA expectations compared to previous estimates [5][6] AEP Performance Highlights - eHealth experienced strong year-over-year growth in submitted Medicare applications, particularly in direct marketing channels [4] - The company achieved an all-time high in AEP submitted application volume in the online unassisted category [4] - Telephonic and online conversion rates exceeded expectations, showing meaningful year-over-year improvement [4] - The LTV-to-CAC ratio improved in the Medicare business, indicating better customer acquisition efficiency [4] - A new comprehensive member retention program successfully encouraged consumers to return to the eHealth platform for coverage reviews and healthcare plan shopping [4] Updated Financial Guidance - Total revenue for fiscal year 2024 is now expected to be between $500 million and $520 million, up from the previous range of $470 million to $495 million [6] - GAAP net income (loss) is projected to range from $(12 million) to $3 million, an improvement from the prior range of $(36.5 million) to $(22 million) [6] - Adjusted EBITDA is expected to be between $40 million and $55 million, significantly higher than the previous range of $7.5 million to $25 million [6] - The updated guidance includes anticipated positive net adjustment revenue of $14 million to $20 million [7] - Operating cash flow is expected to range from $(15 million) to $(5 million), reflecting increased investment in profitable Medicare enrollment growth [7] Management Commentary - The CEO emphasized the company's successful transformation initiatives and AEP preparedness, which contributed to strong consumer demand and enrollment growth [2][3] - The CFO highlighted that the mid-point of the updated guidance suggests substantial margin expansion and attractive cash ROI from the AEP cohort [8]